目前,全球耐药结核病日趋严重,耐药菌株的出现造成了耐药结核病和耐多药结核病遍及世界的任何角落,特别是耐多药肺结核对结核病控制、人类健康构成严重威胁。由于其耐药的种类和数量多,治疗费用剧增,治疗上又是一个棘手问题,临床治愈率明显下降,病死率明显升高。故探索新的治疗方法刻不容缓,针对我院2007年以来住院病人46例耐多药肺结核分别予介入治疗+常规化疗,疗效分析和讨论如下。 Currently, the global drug-resistant TB is worsening. The emergence of drug-resistant strains has led to the spread of drug-resistant TB and MDR-TB anywhere in the world. In particular, MDR-TB is a serious threat to tuberculosis control and human health. Because of its resistance to many types and quantity of treatment costs soared, the treatment is a thorny issue, the clinical cure rate decreased significantly, mortality significantly increased. It is urgent to explore new treatment methods for our hospital since 2007, 46 cases of multidrug-resistant pulmonary tuberculosis inpatients were treated with conventional chemotherapy, the efficacy analysis and discussion are as follows.